U.S. Markets closed

Behind the licensing deal for St. Jude's 'bubble boy' disease cure

Jason Bolton
Behind the licensing deal for St. Jude's 'bubble boy' disease cure

St. Jude and Mustang Bio's exclusive license agreement for the gene therapy could bring in millions of dollars for the hospital.